Neko Health Secures $700 Million in Series C Funding Led by Lightspeed Venture Partners

New Delhi, India Jul 16, 2026 ALN: Neko Health, the body-scanning and health assessment startup founded by Spotify’s Daniel Ek and his co-founder Hjalmar Nilsonne, has successfully raised a $700 million Series C funding round.

The funding round was led by Lightspeed Venture Partners and O.G. Venture Partners, following the company’s previous $260 million Series B round raised in January 2025. This significant influx of capital marks a pivotal moment for Neko Health, as it seeks to expand its innovative health technology offerings and reach more consumers globally.

Neko Health's proprietary body-scanning technology is at the forefront of health assessment innovation. The technology combines detailed body scans with bloodwork to provide a comprehensive overview of an individual's health status. For fitness enthusiasts, the scans yield in-depth body composition metrics, which can be crucial for those looking to optimize their health and fitness regimens. This capability not only aids in personal health management but also serves as a valuable tool for medical professionals who can utilize the data to enhance patient assessments. Moreover, the technology's compatibility with Apple Health data allows for seamless integration of health metrics, enabling clinicians to access real-world data that can inform their medical decisions.

As Neko Health continues to grow, it has already established a presence in the U.K. and Sweden, with plans to launch its first U.S. location in New York. This move into the American market is significant, given the size and potential of the health tech industry in the U.S. The company reports that over 100,000 individuals have undergone scans, with more than 350,000 people currently either registered for the waitlist or scheduled for appointments. This level of interest underscores the growing demand for innovative health solutions that prioritize preventive care and comprehensive health assessments.

The impact of Neko Health's technology is already being felt by individuals who have undergone the scanning process. Notably, Calm founder Alex Tew shared his experience on social media platform X, where he revealed that the scan detected a malignant mole on his back, which he subsequently had removed. Tew expressed his gratitude to Neko Health, stating, “I’m grateful to Neko for helping me discover this – I’m not sure how I would have otherwise.” His story exemplifies the potential life-saving capabilities of early detection through advanced health technologies.

Neko Health operates in a competitive landscape, as it is not the only player in the health scanning sector. Midjourney, an AI lab renowned for its image and video creation technology, is also developing a body scanner. Their plans include integrating this technology into a spa experience that features hot tubs and saunas, set to open in San Francisco in 2027. This indicates a broader trend where health and wellness are increasingly intertwined with technology, with various companies seeking to innovate how individuals engage with their health.

The latest funding round for Neko Health has attracted a host of notable investors, including Atomico, General Catalyst, Lakestar, Liberty City Ventures, Positive Sum, and BDT & MSD. The participation of these investors highlights the confidence in Neko Health’s business model and its potential for growth within the health tech sector. The backing from such reputable firms also suggests that Neko Health is well-positioned to leverage this funding to enhance its product offerings, expand its market reach, and continue its mission of revolutionizing health assessments.

The implications of this funding extend beyond just Neko Health itself. As the health tech industry continues to evolve, the infusion of capital into startups like Neko Health may spur further innovation in the field. With growing consumer demand for accessible and comprehensive health assessments, companies are likely to invest in research and development to enhance their technologies. This could lead to more advanced health monitoring solutions that empower individuals to take charge of their health.

Furthermore, the success of Neko Health may encourage other entrepreneurs and startups to explore similar avenues within the health tech space. As the industry matures, there is a potential for collaboration between tech companies and healthcare providers, which could result in more integrated health solutions that combine technology with traditional medical practices.

In conclusion, Neko Health's recent $700 million Series C funding round marks a significant milestone in the company's journey to transform health assessments through innovative body-scanning technology. With a strong foundation already established in Europe and plans for expansion into the U.S. market, Neko Health is poised to make a substantial impact in the health tech sector. As the company continues to grow and evolve, it will be interesting to observe how it navigates the competitive landscape and the broader implications for health technology as a whole.

The health tech industry has seen remarkable growth in recent years, driven by advancements in technology and an increasing focus on preventive care. Neko Health’s body-scanning technology exemplifies this trend, providing individuals with actionable insights into their health that were previously difficult to obtain outside of a clinical setting. The integration of various health metrics into a single platform not only enhances the user experience but also promotes a more holistic approach to health management.

As consumers become more health-conscious and seek out personalized health solutions, companies like Neko Health are well-positioned to meet this demand. The ability to provide detailed insights into body composition, metabolic health, and other key indicators can empower individuals to make informed decisions about their health. In a world where chronic diseases are on the rise, early detection and preventive measures can play a crucial role in mitigating health risks.

The competitive landscape of health technology is likely to evolve as more players enter the market. Companies that can effectively leverage data analytics and artificial intelligence will likely gain a competitive edge. As Neko Health continues to innovate, it may also explore partnerships with healthcare institutions and fitness organizations to further expand its reach and impact.

The implications of this funding round are also significant for the broader investment community. The health tech sector has attracted considerable interest from venture capitalists, and Neko Health’s successful funding could encourage further investment in similar startups. This influx of capital could lead to a wave of innovation, as new technologies and solutions emerge to address pressing health challenges.

Moreover, the ongoing evolution of telehealth and remote patient monitoring solutions may complement Neko Health’s offerings. As healthcare becomes increasingly digitized, the integration of body-scanning technology with telehealth platforms could create a seamless experience for patients and providers alike. This convergence of technology and healthcare could redefine how health assessments are conducted and how patients engage with their health.

In summary, Neko Health’s ambitious plans and recent funding success highlight the transformative potential of health technology. As the company continues to refine its offerings and expand its footprint, it stands at the forefront of a movement towards more personalized, data-driven health assessments. The future of health technology is bright, and Neko Health is poised to play a significant role in shaping that future.